The Toe-spread-out Exercise in Patients With Hallux Valgus and Without the Deformity
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT03423498 |
|
Recruitment Status :
Completed
First Posted : February 6, 2018
Last Update Posted : February 6, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Hallux Valgus | Other: toe-spread-out exercise | Not Applicable |
Show detailed description
| Study Type : | Interventional (Clinical Trial) |
| Actual Enrollment : | 51 participants |
| Allocation: | Non-Randomized |
| Intervention Model: | Parallel Assignment |
| Masking: | Single (Outcomes Assessor) |
| Primary Purpose: | Treatment |
| Official Title: | The Possibility of the Activation of the Abductor Hallucis Muscle as a Result of the Toe-spread-out Exercise in Patients With Hallux Valgus and in People Without the Deformity: Clinical Trial. |
| Actual Study Start Date : | October 20, 2015 |
| Actual Primary Completion Date : | September 10, 2017 |
| Actual Study Completion Date : | December 20, 2017 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: groups with toe-spread-out exercise
This arm included individuals with hallux valgus (research group A) and without deformation (research group B), who were patients of Department of Rehabilitation, Poznan University of Medical Sciences. They performed the toe-spread-out exercises for 14 days and were examined twice: before and after exercises. The examination of participants included a surface electromyography, electroneurography and goniometer tests to measure the range of motion in the hallux joints.
|
Other: toe-spread-out exercise
The therapeutic intervention lasted 14 days and focused on doing the TSO exercise. This exercise was performed unilaterally under the supervision of a qualified physiotherapist. The starting position of the TSO exercise was the sitting position with the knee joint and hip bent at 90 degrees. The exercise consisted of 3 consecutive phases: dorsiflexion of the toes keeping the metatarsal heads and the heel on the ground, moving the fifth toe down and in a lateral direction, moving the big toe down and abduction. The final position needs to be maintained for 5 seconds. The whole sequence was repeated 200 times a day. |
|
No Intervention: control group
This arm included individuals with hallux valgus deformity from the control group which did not undergo any therapy of hallux. They were patients of Department of Rehabilitation as well. These participants were examined twice at an interval of 14 days in the same way as the patients from experimental arm.
|
- Evaluation of changes in amplitude of motor unit action potential (MUAP) [ Time Frame: 2 weeks (14 days) ]The amplitude of motor unit action potential (MUAP) recorded from the abductor hallucis muscle in three phases of exercise and measured in mV
- Evaluation of changes in frequency pattern of abductor hallucis muscle activity [ Time Frame: 2 weeks (14 days) ]The frequency pattern of the MUAP recruitment of abductor hallucis muscle activity based on the following classification patterns presented by Buchthal et al. and by Stalberg and Falck: interference (IF), intermediate (IM), poor (P) and straight (S).
- Evaluation of changes in amplitude of the CMAP (compound muscle action potential) from the tibial nerve and of the SNAP (sensory nerve action potential) from the sural nerve [ Time Frame: 2 weeks (14 days) ]The amplitude measured from a negative inflection to the baseline in mV.
- Evaluation of changes in latency of the CMAP (compound muscle action potential) from the tibial nerve and of the SNAP (sensory nerve action potential) from the sural nerve [ Time Frame: 2 weeks (14 days) ]The latency measured in ms.
- Evaluation of changes in conduction velocity of the CMAP (compound muscle action potential) from the tibial nerve and of the SNAP (sensory nerve action potential) from the sural nerve [ Time Frame: Time frame: 2 weeks (14 days) ]The conduction velocity measured in m/s.
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 20 Years to 80 Years (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- for patients with hallux valgus (research group A and control group): "B", "C" or "D" score in the Manchester scale, hallux valgus angle above 15° • for healthy volunteers (research group B) "A" score in the Manchester scale, hallux valgus angle equal or lower than 15°
Exclusion Criteria:
- for all groups: a serious injury or a history of lower limb surgery, presence of pain from a disc disease on the background of the disco-radicular conflict (based on the ENG study), neuropathy, myopathy, rheumatoid arthritis, psoriatic arthritis, connective tissue diseases, a history of strokes or other neurological diseases.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03423498
| Poland | |
| Poznan University of Medical Sciences | |
| Poznań, Wielkopolska, Poland, 61-701 | |
| Study Director: | Przemysław Lisiński, MD, PhD | Poznan University of Medical Sciences | |
| Principal Investigator: | Kamila Mortka, Msc | Poznan University of Medical Sciences |
| Responsible Party: | Małgorzata Eliks, Assistant, MSc, Poznan University of Medical Sciences |
| ClinicalTrials.gov Identifier: | NCT03423498 |
| Other Study ID Numbers: |
886/15 |
| First Posted: | February 6, 2018 Key Record Dates |
| Last Update Posted: | February 6, 2018 |
| Last Verified: | February 2018 |
| Individual Participant Data (IPD) Sharing Statement: | |
| Plan to Share IPD: | Undecided |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |
|
hallux valgus, toe-spread-out exercise abductor hallucis muscle surface electromyography |
|
Hallux Valgus Bunion Foot Deformities Musculoskeletal Diseases Foot Deformities, Acquired |

